For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Cisatracurium (Non-depolarising neuromuscular blocking agent (benzylisoquinolinium)) – indications: Intubation (elective, adults), Repeat dose, Continuous infusion (theatre), Neuromuscular blockade in ventilated ICU patients. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Intubation (elective, adults)
- Repeat dose
- Continuous infusion (theatre)
- Neuromuscular blockade in ventilated ICU patients
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Sources and guidelines
- Summaries of product characteristics of authorised products – product and section for each dose in the app.